Hypofractionated stereotactic radiation therapy activates the peripheral immune response in operable stage I non-small-cell lung cancer

It has been reported that in patients with operable stage I non-small cell lung cancer (NSCLC), overall survival (OS) is better in those who undergo hypofractionated stereotactic radiation therapy (HSRT) than in those who undergo surgery. However, the reason that HSRT has a better OS has not been fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ting, Yu, Haifeng, Ni, Chao, Zhang, Tao, Liu, Luying, Lv, Qinghua, Zhang, Zhigang, Wang, Zhen, Wu, Dang, Wu, Pin, Chen, Guodi, Wang, Liancong, Wei, Qichun, Huang, Jian, Wang, Xiaojian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501824/
https://www.ncbi.nlm.nih.gov/pubmed/28687760
http://dx.doi.org/10.1038/s41598-017-04978-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501824/
https://www.ncbi.nlm.nih.gov/pubmed/28687760
http://dx.doi.org/10.1038/s41598-017-04978-x

Ejemplares similares